EVA Basel
6
2M
5
0.23
3
0.17
- Stages of investment
- Areas of investment
Summary
EVA Basel appeared to be the Corporate Investor, which was created in 1996. The main department of described Corporate Investor is located in the Basel. The company was established in Europe in Switzerland.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the EVA Basel, startups are often financed by Venture Kick, Zu00fcrcher Kantonal Bank, Neuromuscular Research Association Basel. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, StartAngels Network, Redalpine Venture Partners. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, SHS Gesellschaft fur Beteiligungsmanagement, Novo Seeds.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Robotics, Manufacturing. Among the various public portfolio startups of the fund, we may underline Memo Therapeutics, AOT - Advanced Osteotomy Tools, BioVersys AG The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2015.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 3
- Rounds per year
- 0.23
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (5)
- Pharmaceutical (3)
- Medical Device (3)
- Medical (2)
- Communities (2) Show 6 more
- Investments by region
-
- Switzerland (6)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Memo Therapeutics | 22 Jul 2015 | Biotechnology, Collaboration | Early Stage Venture | 2M | Switzerland, Zurich, Zurich |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.